Liberty Health Sciences Increases Size of Bought Deal Financing

Liberty Health Sciences (CSE:LHS) announced it has increased the size of its bought deal offering, which will now be for 9,523,810 units of the company at a price of $2.10 per unit.
As quoted in the press release:

Each Unit will be comprised of one common share of the Company (a “Unit Share”) and one-half of one common share purchase warrant (each whole common share purchase warrant, a “Warrant”). Each Warrant will entitle the holder thereof to purchase one common share of the Company (a “Warrant Share”) at a price of C$2.65 per Warrant Share for a period of 24 months following the Closing Date (as defined below).
The Company has also agreed to grant the Underwriters an over-allotment option to purchase an additional 1,428,571 Units at the Offering Price, exercisable in whole or in part, for a period ending 30 days from and including the Closing Date. In the event the over-allotment option is exercised in full, the aggregate gross proceeds of the Offering will be C$23,000,000.10.

Click here to read the full press release.